March 2022

Study: Sub dissociative dose of ketamine with haloperidol versus fentanyl on pain reduction in patients with acute pain in the emergency department; a randomized clinical trial

This study came in through my notifications today, but it was published two weeks ago on Clinical Pain Advisor. I also remember seeing this study being discussed on social media and online forums a few weeks ago. I meant to write it up then, but… Read More »Study: Sub dissociative dose of ketamine with haloperidol versus fentanyl on pain reduction in patients with acute pain in the emergency department; a randomized clinical trial

GUIDELINE FOR DEPRESCRIBING OPIOID ANALGESICS

This is important for every Australian who is on long-term opioid therapy for chronic pain https://www.opioiddeprescribingguideline.com Most people in the chronic pain community will not be aware that there are Draft Opioid Deprescribing Guidelines currently open for public comment. The Draft Guidelines and a template… Read More »GUIDELINE FOR DEPRESCRIBING OPIOID ANALGESICS

Study: “One Size Fits All” Doesn’t Fit When It Comes to Long-Term Opioid Use for People with Chronic Pain

M. E. Lynch &J. KatzPublished online: 04 May 2017 Information courtesy of Kev James, Chronic Pain Patient Advocate. LinkedIn Source: https://www.tandfonline.com/doi/full/10.1080/24740527.2017.1319733 This study pulls no punches: “The use of opioids in chronic non-cancer pain continues to be a flashpoint in medicine. The media and others… Read More »Study: “One Size Fits All” Doesn’t Fit When It Comes to Long-Term Opioid Use for People with Chronic Pain

Study: Appropriate and responsible use of opioids in chronic non-cancer pain

Harald Breivik First published: 09 January 2012 Information courtesy of Kev James, Chronic Pain Patient Advocate. LinkedIn Read the full study here In 2012 a group of distinguished pain clinicians from nine European countries got together to discuss the appropriate use of strong opioids for… Read More »Study: Appropriate and responsible use of opioids in chronic non-cancer pain

Study: Long-term use of controlled-release oxycodone for noncancer pain: results of a 3-year registry study

After three months of treatment, the large majority of patients, who were on stable doses, the average pain intensity scores were unchanged or improved for approximately 70 to 80% of patients. The most common adverse events were not serious, including constipation and nausea, and the incidence of these events declined over time on treatment.

Are opioids safe and effective for chronic non-cancer pain? Summary of the evidence

Chronic non-cancer pain – It is oft said that opioids are not effective long term, and that chronic non-cancer pain should not be treated with opioids for this reason. It is said that there is ‘no evidence that opioids work for pain long term’ and this lack of evidence is regarded as evidence.

The ‘science’ behind 90MME as the upper limit for opioids prescribed for chronic pain

In 2016 the US Centers for Disease control (CDC) released guidelines on the prescribing of opioids for chronic pain in an effort to reduce opioid overdose deaths. These guidelines had disastrous consequences for US chronic non-cancer pain (CNCP) patients, many of whom were force tapered… Read More »The ‘science’ behind 90MME as the upper limit for opioids prescribed for chronic pain